2025 Q3 Portfolio Activity
In 2025 Q3, Qiming U.S. Ventures Management, LLC maintained a portfolio of 6 distinct positions. Conversely, Qiming U.S. Ventures Management, LLC completely exited their position in VENTYX BIOSCIENCES INC.
Position History
hover any row below to update
Loading…
Total Positions
6
Quarter
2025 Q3
Top Holding
TRML (63.8%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-6 of 6
Qiming U.S. Ventures Management, LLC Full Holdings List — 2025 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TRML
TOURMALINE BIO ...
|
Unknown | 63.76% | 50.22% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
741,691 | $35,475,081 | 2023 Q4 | 13F Filing | 2025-09-30 | 2025-11-14 (Est.) | |||
|
KRRO
KORRO BIO INC
|
Healthcare | 31.68% | 19.47% |
#2
1
Prev: #3
|
6.5 |
—
|
no change | no change |
P
S
|
368,085 | $17,627,591 | 2023 Q4 | 13F Filing | 2025-09-30 | 2025-11-14 (Est.) | |||
|
JSPR
JASPER THERAPEU...
|
Healthcare | 3.97% | 21.83% |
#3
1
Prev: #2
|
3.6 |
—
|
no change | no change |
P
S
|
928,964 | $2,210,934 | 2024 Q1 | 13F Filing | 2025-09-30 | 2025-11-14 (Est.) | |||
|
KZR
KEZAR LIFE SCIE...
|
Healthcare | 0.58% | 1.61% |
#4
2
Prev: #6
|
1.7 |
—
|
no change | no change |
P
S
|
82,871 | $323,197 | 2021 Q4 | 13F Filing | 2025-09-30 | 2025-11-14 (Est.) | |||
|
HLVX
HILLEVAX INC
|
Unknown | 0.00% | 3.14% |
Sold All 😨
(Was: #5) |
0.0 |
—
|
-372,615 | -100.0% |
CLOSED
|
— | $— | 2022 Q2 | 13F Filing | 2025-09-30 | 2025-11-14 (Est.) | |||
|
VTYX
VENTYX BIOSCIEN...
|
Healthcare | 0.00% | 3.74% |
Sold All 😨
(Was: #4) |
0.0 |
—
|
-412,225 | -100.0% |
CLOSED
|
— | $— | 2021 Q4 | 13F Filing | 2025-09-30 | 2025-11-14 (Est.) |
Showing 1-6 of 6 holdings